In patients with NAFLD, Fetuin-A levels were associated with the severity of steatosis, were influenced by genetic risk factors for hepatic fat accumulation and also correlated with insulin resistance and metabolic syndrome features [199]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.